Find News

Filter articles

Showing 91 to 100 of 3709 results

Novartis, Dana-Farber seek to bar generic leukaemia drug

US09-06-2022Muireann Bolger

Novartis Pharmaceuticals and the Dana-Farber Cancer Institute have filed two lawsuits to bar generic versions of leukaemia drug, Rydapt.

Senators urge USPTO to curb ‘patent thicket’ abuse


A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.

Pfizer sues MSN Labs over Xeljanz generic

US09-06-2022Muireann Bolger

Pfizer has sued MSN Laboratories to prevent the rollout of generic copies of the blockbuster drug Xeljanz, used to treat patients with arthritis.

Arbutus, Genevant reject Moderna’s vaccine patent defence

US07-06-2022Sarah Speight

Moderna’s bid to avoid a COVID-19 patent claim has been rejected by two pharma companies that are suing the vaccine manufacturer for infringing its drug delivery technology.

California judge approves BMS $10.8m settlement


A judge at the US District Court for the Northern District of California has granted a motion for preliminary approval of a $10.8 million settlement in an antitrust suit.

Illumina urges court to overturn DNA patent verdict


Biotech company Illumina has asked a Delaware court to overturn a finding that it willfully infringed two DNA sequencing patents and must pay $334 million in damages.

GSK bets $2.1bn on Boston-based biopharma company

UK, US01-06-2022

GlaxoSmithKline has agreed to acquire Affinivax, a clinical-stage biopharmaceutical company based in Cambridge, Boston and focusing on developing vaccines.

J&J units launch prostate cancer drug suit

US31-05-2022Sarah Speight

Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

Pfizer commits to offer drugs not-for-profit to 45 low-income countries

Ghana, Switzerland, US31-05-2022

Pfizer has announced that it will provide all of its current and future patent-protected medicines and vaccines—that are available in the US or EU—on a not-for-profit basis to 45 lower-income countries.

UK regulators no longer exempt from paying successful parties' costs

UK26-05-2022Muireann Bolger

The UK Supreme Court has ruled that regulators such as the Competition and Markets Authority should be required to pay the costs of a party successfully appealing against one of their infringement decisions.

Showing 91 to 100 of 3709 results